» Articles » PMID: 3719375

Serotonin Receptors in the Human Brain. I. Characterization and Autoradiographic Localization of 5-HT1A Recognition Sites. Apparent Absence of 5-HT1B Recognition Sites

Overview
Journal Brain Res
Specialty Neurology
Date 1986 Jun 18
PMID 3719375
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

The presence, pharmacological properties and anatomical distribution of serotonin-1A and serotonin-1B receptor subtypes were studied in the human brain by both radioligand binding assays and autoradiographic procedures. Frontal cortices and hippocampi from human brains obtained at autopsy without evidence of neurological disease were used in this study. [3H]5-HT was used to label both 5-HT1A and 5-HT1B receptor subtypes. 5-HT1A receptors were selectively labeled by [3H]8-hydroxy-2[di-N-propylamino]tetralin, while 5-HT1B receptors were labeled by (-)-[125I]iodocyanopindolol ([125I]CYP) in the presence of 30 microM isoprenaline. The pharmacological profile of 5-HT1A receptors in human brain tissue was very similar to those previously found in rat and pig brain tissues. The general anatomical distribution of these sites was also similar to that found in the rat brain, although some differences were observed when analyzed at the microscopic level. In contrast to 5-HT1A receptors, it was not possible to identify 5-HT receptors having the pharmacological properties of 5-HT1B sites in the human brain, using either [3H]5-HT or [125I]CYP as ligands. The absence of identifiable 5-HT1B receptors in human brain preparations, a fact previously found in pig brain tissue, is discussed in terms of the existence of species differences in brain serotonin receptors.

Citing Articles

Cannabidiol for neurodegenerative disorders: A comprehensive review.

Bhunia S, Kolishetti N, Arias A, Vashist A, Nair M Front Pharmacol. 2022; 13:989717.

PMID: 36386183 PMC: 9640911. DOI: 10.3389/fphar.2022.989717.


International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S Pharmacol Rev. 2020; 73(1):310-520.

PMID: 33370241 PMC: 7770494. DOI: 10.1124/pr.118.015552.


Synthesis, in vitro and in vivo evaluation of C-O-methylated arylpiperazines as potential serotonin 1A (5-HT) receptor antagonist radiotracers.

Narayanaswami V, Tong J, Fiorino F, Severino B, Sparaco R, Magli E EJNMMI Radiopharm Chem. 2020; 5(1):13.

PMID: 32430632 PMC: 7237647. DOI: 10.1186/s41181-020-00096-8.


From to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases.

Cassano T, Villani R, Pace L, Carbone A, Naik Bukke V, Orkisz S Front Pharmacol. 2020; 11:124.

PMID: 32210795 PMC: 7069528. DOI: 10.3389/fphar.2020.00124.


Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity.

Underwood M, Kassir S, Bakalian M, Galfalvy H, Dwork A, Mann J Transl Psychiatry. 2018; 8(1):279.

PMID: 30552318 PMC: 6294796. DOI: 10.1038/s41398-018-0309-1.